In the last three months, 4 analysts have published ratings on 10x Genomics (NASDAQ:TXG), offering a diverse range of perspectives from bullish to bearish.

The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months.

Analysts have set 12-month price targets for 10x Genomics, revealing an average target of $54.5, a high estimate of $63.00, and a low estimate of $45.00. This current average represents a 4.39% decrease from the previous average price target of $57.00.

Investigating Analyst Ratings: An Elaborate Study

The analysis of recent analyst actions sheds light on the...